SignatureFD’s Myovant Sciences Ltd. MYOV Stock Holding History

SignatureFD’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-35	Closed	-$1K	–	3336
2021 Q3	$1K	Sell	35 -92	-72%	-$2.02K	﹤0.01%	2981
2021 Q2	$3K	Buy	+127	New	+$2.67K	﹤0.01%	2517

Other funds holding MYOV

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

SignatureFD's MYOV Position: Q4 2021 in Review

SignatureFD sold out of Myovant Sciences Ltd. (MYOV) in Q4 2021, closing a stake of 35 shares — an estimated $1K sold.

SignatureFD first reported a position in MYOV in Q2 2021 and held it in 2 quarters. The position peaked at $3K in Q2 2021. 110 funds tracked by Wall St. Rank hold MYOV as of Q4 2021.

SignatureFD reported no remaining Myovant Sciences Ltd. position as of Q4 2021 after selling out during the quarter.
SignatureFD sold 35 Myovant Sciences Ltd. shares in Q4 2021, an estimated $1K.
SignatureFD first reported a position in Myovant Sciences Ltd. in Q2 2021 and held it in 2 quarters.
SignatureFD's Myovant Sciences Ltd. position peaked at $3K in Q2 2021.
110 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2021.

Based on SignatureFD's 13F filing for Q4 2021, filed 25 Jan 2022.